Home > Insider Trading > Filing (0000950170-23-021364)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785173	89Bio Inc.	ETNB	Pharmaceutical Preparations (2834)	831114349

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792062	Quoc Le-Nguyen	C/O 89Bio, Inc. 142 Sansome Street, 2Nd Floor San Francisco CA 94104	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-05-09	60,945	$3.11	160,028	No	4	M	Direct
Common Stock	Acquisiton	2023-05-09	18,626	$3.11	178,654	No	4	M	Direct
Common Stock	Disposition	2023-05-09	13,683	$18.11	164,971	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-05-09	60,945	$0.00	60,945	$3.11
Common Stock	Stock Option (Right to Buy)	Disposition	2023-05-09	18,626	$0.00	18,626	$3.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,063			No	4	M	Direct
3,312			No	4	M	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 3, 2023.
This option represents a right to purchase a total of 65,008 shares of the Issuer's common stock and is vested in full.
This option represents a right to purchase a total of 26,486 shares of the Issuer's common stock, one quarter of which vested on July 23, 2020, with the remaining three quarters vesting in equal quarterly installments over the following three years.